Weng Min-Hsueh
Department of Nursing, Tri-Service General Hospital, 325 Sec. 2, Chengkung Road, Neihu 114, Taipei, Taiwan.
Intensive Crit Care Nurs. 2008 Oct;24(5):295-9. doi: 10.1016/j.iccn.2007.11.005. Epub 2008 Feb 1.
In acute respiratory failure, non-invasive ventilation (NIV) treatment is used to prevent the need for intubation. NIV applied through a face mask may contribute to the development of facial skin lesions. This study was conducted to compare the efficacy of protective dressings and of using no materials for pressure ulcer prevention.
There were 90 participants in this study. The participants were assigned into three groups: control group, tegasorb group, and tegaderm group.
The tegasorb group and tegaderm group, in contrast to the control group, had fewer pressure ulcers based on our statistics and occurrence duration time (p<.01). However, there were no significant difference in occurrence duration time between the tegasorb group and tegaderm group.
This result revealed that tegasorb and tegaderm could be used on the face of NIV patients to prevent pressure ulcers.
在急性呼吸衰竭中,使用无创通气(NIV)治疗以避免插管的需要。通过面罩进行的无创通气可能会导致面部皮肤损伤。本研究旨在比较预防性敷料与不使用任何材料预防压疮的效果。
本研究有90名参与者。参与者被分为三组:对照组、德湿可吸收性敷料组和泰德玛敷料组。
根据我们的统计,与对照组相比,德湿可吸收性敷料组和泰德玛敷料组的压疮数量更少,且发生持续时间更短(p<0.01)。然而,德湿可吸收性敷料组和泰德玛敷料组在发生持续时间上没有显著差异。
该结果表明,德湿可吸收性敷料和泰德玛敷料可用于无创通气患者的面部以预防压疮。